The first bioactive peptide isolated from pearl matrix protein — KKCHFWPFPW — competitively inhibits ACE with an IC50 of 4.17 μM, revealing pearls as a novel source of potential antihypertensive agents.
IC50: 4.17 μMThe first bioactive peptide isolated from pearl matrix protein — KKCHFWPFPW — competitively inhibits ACE at this concentration
What the researchers found
KKCHFWPFPW (MW 1417.5 Da, pI 9.31) from Pinctada fucata pearl matrix competitively inhibits ACE with IC50 of 4.17 μM, confirmed by Lineweaver-Burk plot analysis and molecular docking simulations.
Why it matters
This discovery adds pearls to the growing list of unexpected natural sources of bioactive peptides. While the practical applications are still far off, it demonstrates that traditional remedies sometimes contain genuine pharmacological compounds waiting to be discovered with modern analytical tools.
The numbers in context
Peptide KKCHFWPFPW: molecular weight 1417.5 Da, isoelectric point 9.31. First ACE-inhibiting peptide from pearl matrix.
How the study worked
Pearl matrix protein from Pinctada fucata was processed and peptides identified by quadrupole time-of-flight mass spectrometry. ACE inhibition was quantified by HPLC (IC50 determination). Inhibition kinetics analyzed by Lineweaver-Burk plots. Molecular docking simulations (Maestro 2022-1 Glide) characterized the peptide-ACE binding interaction.
Who was studied
Pearl matrix protein from Pinctada fucata
What this study cannot tell us
In vitro study only — no evidence the peptide survives digestion or reaches the bloodstream. The IC50 of 4.17 μM is moderate compared to pharmaceutical ACE inhibitors. Pearl protein is not a practical food source for most people. The molecular docking is computational prediction, not experimentally confirmed binding. No cell or animal studies.
How to read the evidence
Preliminary evidence from in vitro enzyme assays and computational docking. First-of-its-kind discovery with no animal or human data yet.
When this study was published
Published in 2024, representing a novel discovery at the intersection of traditional medicine and modern peptide biochemistry.
The bigger picture
Food-derived and natural ACE-inhibitory peptides are a growing field, with peptides from milk, fish, soybeans, and now pearls. While none have matched the potency of pharmaceutical ACE inhibitors, they represent potential functional food ingredients and validate traditional medicine claims. The discovery of bioactive peptides in such an unexpected source underscores how much remains to be discovered in natural biomaterials.
Questions still open
- Does KKCHFWPFPW survive gastrointestinal digestion and reach the bloodstream intact?
- Are there additional bioactive peptides in pearl matrix that could work synergistically?
- Could pearl protein hydrolysates be developed into functional food supplements?
Common questions
Does this mean pearls can lower blood pressure?
How does this compare to actual blood pressure medications?
Read the original research
The first bioactive (angiotensin-converting enzyme-inhibitory) peptide isolated from pearl matrix protein.
Heliyon, 10(7), e28060
Citation
Wu, Chaoyi; Yin, Zehui; Wang, Yayu; Chen, Xinjiani; Li, Bailei; Wang, Qin; Yao, Liping; Zhang, Zhen; Liu, Xiaojun; Zhang, Rongqing. (2024). The first bioactive (angiotensin-converting enzyme-inhibitory) peptide isolated from pearl matrix protein.. Heliyon, 10(7), e28060. https://doi.org/10.1016/j.heliyon.2024.e28060